Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S Patients.

Mabrouk, Omar S; Chen, Siwei; Edwards, Amanda L; Yang, Minhua; Hirst, Warren D; Graham, Danielle L

Mabrouk, Omar S; Chen, Siwei; Edwards, Amanda L; Yang, Minhua; Hirst, Warren D; Graham, Danielle L.

Afiliación

Mabrouk OS; Clinical Sciences, Biomarkers, Biogen, Cambridge, MA, United States.
Chen S; Clinical Sciences, Biomarkers, Biogen, Cambridge, MA, United States.
Edwards AL; Clinical Sciences, Biomarkers, Biogen, Cambridge, MA, United States.
Yang M; Biostatistics, Biogen, Cambridge, MA, United States.
Hirst WD; Neurodegeneration Research Unit, Biogen, Cambridge, MA, United States.
Graham DL; Clinical Sciences, Biomarkers, Biogen, Cambridge, MA, United States.

Front Neurosci ; 14: 526, 2020.

Article en En | MEDLINE | ID: mdl-32523511

Palabras clave

G2019S; LRRK2; Parkinson's disease; SISCAPA; biomarkers; cerebrospinal fluid; exosome; mass spectrometry

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Front Neurosci Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google